U.S. stocks turned lower toward the end of trading, with the Dow Jones falling more than 100 points on Monday.
The Dow traded down 0.43% to 32,703.03 while the NASDAQ fell 0.58% to 12,318.87. The S&P also fell, dropping, 0.65% to 4,102.85.
Also check this: Bitcoin, Ethereum Record Losses; Here Are Other Crypto Movers That Should Be On Your Radar Today
Leading and Lagging Sectors
Consumer staples shares climbed 1.3% on Monday. Meanwhile, top gainers in the sector included Bridgford Foods Corporation BRID, up 15% and Celsius Holdings, Inc. CELH up 12%.
In trading on Monday, energy shares fell 3.2%.
Top Headline
The ISM manufacturing PMI fell to 52.8 in July from 53 in the previous month. However, analysts were expecting a reading of 52.
Equities Trading UP
TherapeuticsMD, Inc. TXMD shares shot up 36% to $8.47 after the company announced it has received a $15 million private investment from Rubric Capital Management.
Shares of Celyad Oncology SA CYAD got a boost, shooting 40% to $2.4399. The FDA has lifted the clinical hold on Celyad Oncology’s CYAD-101-002 (KEYNOTE-B79) Phase 1b trial after the company made changes to the eligibility criteria for the trial.
MediaCo Holding Inc. MDIA shares were also up, gaining 99% to $4.12. MediaCo Holding 10% owner Soohyung Kim bought a total of 12,899,480 shares at an average price of $2.32.
Equities Trading DOWN
Kazia Therapeutics Limited KZIA shares tumbled 47% to $1.9031 after the company announced its GBM AGILE pivotal study for paxalisib did not meet the pre-defined criteria for continuing to a second stage.
Shares of Zovio Inc ZVO were down 33% to $0.6901 as the company reported a second-quarter FY22 sales decline of 25.7% year-on-year, to $51.38 million.
Otonomy, Inc. OTIC was down, falling 79% to $0.2990 after the company announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
Also check out: Market Volatility Declines Slightly On The First Trading Day Of August
Commodities
In commodity news, oil traded down 5% to $93.77, while gold traded up 0.3% to $1,786.50.
Silver traded up 0.7% to $20.345 on Monday while copper fell 1.4% to $3.5235.
Euro zone
European shares closed mostly lower today. The eurozone’s STOXX 600 fell 0.19%, London’s FTSE 100 declined 0.13% while Spain’s IBEX 35 Index fell 0.87%. The German DAX slipped 0.03%, French CAC 40 fell 0.18% and Italy’s FTSE MIB Index gained 0.11%.
The unemployment rate in the Eurozone came in unchanged at 6.6% for June, while manufacturing PMI fell to 49.8 in July from 52.1 in June. Retail sales in Germany declined 1.6% month-over-month in June versus a revised 1.2% increase in May, while the country’s manufacturing PMI rose to 49.3 in July from a preliminary level of 49.2.
The S&P Global/CIPS UK manufacturing PMI fell to 52.1 in July from a preliminary reading of 52.2, while Italian manufacturing PMI declined to 48.5 in July from 50.9 in June. The S&P Global manufacturing PMI for France dropped to 49.5 in July from 51.4 a month ago.
Economics
The S&P Global manufacturing PMI fell to 52.2 in July from a preliminary reading of 52.3.
The ISM manufacturing PMI fell to 52.8 in July from 53 in the previous month. However, analysts were expecting a reading of 52.
Construction spending dropped by 1.1% from the prior month to an annual rate of $1.76 trillion in June.
Check out this: Why Fear Level Among US Investors Is Decreasing
COVID-19 Update
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 93,082,190 cases with around 1,055,050 deaths. India confirmed a total of at least 44,036,270 cases and 526,390 deaths, while France reported over 33,859,570 COVID-19 cases with 151,980 deaths. In total, there were at least 582,459,460 cases of COVID-19 worldwide with more than 6,420,210 deaths.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.